SNPS

Synopsys
D

SNPS

Arincen72/100B

Synopsys shares outstanding 1990–2026

Synopsys had 191,636,646 shares outstanding on 8 November 2026. Synopsys had 176.82M diluted shares on average over the last twelve months, up 12.3% on the twelve months before. In fiscal year 2025 the average was 161.68M.

Last updated 6 Nov 2026 · Next report 8 Dec 2026

Shares outstanding

Change on the year

Fiscal yearPeriod endingShares outstandingChange on the yearBasic shares
TTM31 Jul 2026176.82M+12.27%175.60M
FY202531 Oct 2025161.68M+3.68%160.17M
FY202431 Oct 2024155.94M+0.48%153.14M
FY202331 Oct 2023155.20M-0.82%152.15M
FY202231 Oct 2022156.49M-0.54%153.00M
FY202131 Oct 2021157.34M+1.05%152.70M
FY202031 Oct 2020155.71M+0.98%151.14M
FY201931 Oct 2019154.19M+0.52%149.87M
FY201831 Oct 2018153.39M-0.96%149.04M
FY201731 Oct 2017154.87M+0.10%150.46M
FY201631 Oct 2016154.72M-2.12%152.02M
FY201531 Oct 2015158.07M+0.23%154.96M
FY201431 Oct 2014157.71M+0.71%155.05M
FY201331 Oct 2013156.60M+4.21%153.32M
FY201231 Oct 2012150.28M-0.06%146.89M
FY201131 Oct 2011150.37M-1.02%146.57M
FY201031 Oct 2010151.91M+4.15%148.01M
FY200931 Oct 2009145.86M-1.23%143.75M
FY200831 Oct 2008147.67M-1.37%143.26M
FY200731 Oct 2007149.72M+3.45%143.95M
FY200631 Oct 2006144.73M-0.17%142.83M
FY200531 Oct 2005144.97M-8.34%144.97M
FY200431 Oct 2004158.16M-3.87%151.71M
FY200331 Oct 2003164.53M+24.23%157.60M
FY200231 Oct 2002132.45M+2.42%132.45M
FY200131 Oct 2001129.32M-8.93%121.20M
FY200031 Oct 2000142.00M-3.30%137.02M
FY199930 Sept 1999146.84M+5.61%140.24M
FY199830 Sept 1998139.05M+5.98%133.14M
FY199730 Sept 1997131.20M+57.44%125.19M
FY199630 Sept 199683.33M-11.99%83.33M
FY199530 Sept 199594.69M+27.67%94.69M
FY199430 Sept 199474.17M+17.99%74.17M
FY199330 Sept 199362.86M+6.24%62.86M
FY199230 Sept 199259.17M+18.33%59.17M
FY199130 Sept 199150.00M+12.50%50.00M
FY199030 Sept 199044.44M—44.44M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,EPS,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about Synopsys's shares

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.